ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia
International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.